Status:
UNKNOWN
Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus
Lead Sponsor:
Misr University for Science and Technology
Conditions:
COVID-19
Eligibility:
All Genders
5-75 years
Phase:
PHASE3
Brief Summary
The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) has been discovered recently in December 2019 from wuhan city in China to spread in...
Detailed Description
The (SARS CoV-2) virus is spreading globally, threatening all healthcare systems. Many healthcare systems and organizations are using different protocols and measures to fight the COVID-19. Hydroxychl...
Eligibility Criteria
Inclusion
- Meeting the criteria for diagnosis of COVID-19, either clinically or as confirmed by positive swap.
Exclusion
- Children below 5 years old. Severely ill patients with either terminal disease. Nil per os (NPO) patients with contraindication to nasogastric tube feeding.
Key Trial Info
Start Date :
April 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 15 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04323345
Start Date
April 15 2020
End Date
January 15 2021
Last Update
April 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mahmoud Tantawy
Cairo, Egypt